Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses

臺大醫學院-臨床醫學研究所;Liu, Chun-JenChun-JenLiuYu, Ming-LungMing-LungYuLee, Chuan-MoChuan-MoLeeChen, Chi-LingChi-LingChenChuang, Wan-LongWan-LongChuangWu, Shun-ShengShun-ShengWuYang, Sien-SingSien-SingYangKao, Jia-HorngJia-HorngKaoLin, Chih-LinChih-LinLinChen, Pei-JerPei-JerChenChen, Ding-ShinnDing-ShinnChen2017-06-222018-07-062017-06-222018-07-062012http://ntur.lib.ntu.edu.tw//handle/246246/279492[SDGs]SDG3Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses